Skip to main content
Fig. 1 | BMC Immunology

Fig. 1

From: Oncolytic herpes simplex virus and immunotherapy

Fig. 1

Mechanisms of oncolytic virus selective killing tumor cells. Local replication of oncolytic virus induces lysis of tumor cells results in release of tumor-derived antigens which promote the activity of the cancer-immunity cycle, resulting in the specific antitumor immunity in the course of its oncolytic activities that act on remote lesions, ultimately killing the tumor cells selectively

Back to article page